Bittium Corporation, Stock Exchange Release, July 11, 2025, at 1.00 pm (CEST+1) Bittium Corporation publishes this stock exchange release to comment on the market information regarding the possible ...

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules ...

Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received order for an NBS 6 system from a distributor. The end customer is a Nordic therapy clinic that is acquiring their first Nexstim system.

Prior to joining Bitwise, Shannon served as a Crypto & Equity Research Analyst at CoinShares, where he specialized in liquid tokens and publicly listed crypto-related companies. His expertise in ...

Solar Foods partners with Sensapure Flavors to showcase Solein's suitability for endless flavour combinations ...

Glass succeeds Randy Curran, who recently retired from the CEO role. “We thank Randy for his leadership and the pivotal role he played over the past three years at TrueCommerce,” said Glass. “His ...

In Q2 we were also joined by Gregor Bates, Associate, London, and Analysts Matt Farrell, Nikita Spivakov, and Tim O’Callaghan in New York. We also welcome George Parker, New York, as Senior Advisor ...

After four intense days, the Yacht Club de Monaco concluded the 12th edition of the Monaco Energy Boat Challenge. Uniboat-University of Bologna Argonauts Team, supported by Sanlorenzo, was crowned ...

Gold production from ongoing operations of 61,736 ounces; compared to 56,000 oz Au in Q2 20241,2 and 58,820 oz Au in Q1 20251,3 Gold equivalent production from ongoing operations of 71,229 ounces4 ...

Heineken® identified by 62% of Formula 1® fans as the number one drinks brand that encourages responsible consumption.

A new European leadership structure and the integration of Smart Mobile Labs under the Boldyn banner reinforce Boldyn’s position as the leading neutral host and mobile private networks provider in the ...

Earlier this year, Purespring announced that the European Medicines Agency (EMA) had granted orphan drug designation to PS-002 for the treatment of patients with IgAN. This designation followed the ...